Transfection with siCALM1 decreased CaM expression in activated HD T cells by 30% as compared to scr-RNA-transfected cells (Figure 6A); a reduction in CaM expression comparable to that observed in activated HNSCC T cells (Figure 1H). Here, CALM2 is linked to head and neck squamous cell carcinoma.